These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
123 related items for PubMed ID: 3720944
1. 2,2'-Bipyridyl-6-carbothioamide derivatives as potential antitumor agents. Antonini I, Cristalli G, Franchetti P, Grifantini M, Martelli S, Filippeschi S. Farmaco Sci; 1986 May; 41(5):346-54. PubMed ID: 3720944 [Abstract] [Full Text] [Related]
2. 2,2'-Bipyridyl-6-carboxamidoximes with potential antitumor and antimicrobial properties. Cristalli G, Franchetti P, Grifantini M, Ripa S. Farmaco Sci; 1986 Jul; 41(7):499-507. PubMed ID: 3743743 [Abstract] [Full Text] [Related]
3. N*-N*-S* tridentate ligand system as potential antitumor agents. Antonini I, Claudi F, Cristalli G, Franchetti P, Grifantini M, Martelli S. J Med Chem; 1981 Oct; 24(10):1181-4. PubMed ID: 7328579 [Abstract] [Full Text] [Related]
4. Some mixed-ligand palladium(II) complexes of 2,2'-bipyridine and amino acids as potential anticancer agents. Puthraya KH, Srivastava TS, Amonkar AJ, Adwankar MK, Chitnis MP. J Inorg Biochem; 1985 Nov; 25(3):207-15. PubMed ID: 4067607 [Abstract] [Full Text] [Related]
5. Isolation of two cellular lines resistant to ribonucleotide reductase inhibitors to investigate the inhibitory activity of 2,2'-bipyridyl-6-carbothioamide. Nocentini G, Federici F, Armellini R, Franchetti P, Barzi A. Anticancer Drugs; 1990 Dec; 1(2):171-7. PubMed ID: 2131050 [Abstract] [Full Text] [Related]
6. [Synthesis of bis-(pirydylmethyl)amines]. Niewiadomski K. Acta Pol Pharm; 1976 Dec; 33(3):307-10. PubMed ID: 7922 [No Abstract] [Full Text] [Related]
7. Antitumor activity of 2,2'-bipyridyl-6-carbothioamide: a ribonucleotide reductase inhibitor. Nocentini G, Barzi A. Gen Pharmacol; 1997 Nov; 29(5):701-6. PubMed ID: 9347313 [Abstract] [Full Text] [Related]
8. Gold(III) complexes with bipyridyl ligands: solution chemistry, cytotoxicity, and DNA binding properties. Marcon G, Carotti S, Coronnello M, Messori L, Mini E, Orioli P, Mazzei T, Cinellu MA, Minghetti G. J Med Chem; 2002 Apr 11; 45(8):1672-7. PubMed ID: 11931621 [Abstract] [Full Text] [Related]
9. Implications and problems in analysing cytotoxic activity of hydroxyurea in combination with a potential inhibitor of ribonucleotide reductase. Nocentini G, Barzi A, Franchetti P. Cancer Chemother Pharmacol; 1990 Apr 11; 26(5):345-51. PubMed ID: 2208576 [Abstract] [Full Text] [Related]
10. Generation by mutasynthesis of potential neuroprotectant derivatives of the bipyridyl collismycin A. Sialer C, García I, González-Sabín J, Braña AF, Méndez C, Morís F, Salas JA. Bioorg Med Chem Lett; 2013 Oct 15; 23(20):5707-9. PubMed ID: 23993774 [Abstract] [Full Text] [Related]
11. Synthesis, spectroscopic, mutagenic, and cytotoxicity studies of some mixed-ligand platinum(II) complexes of 2,2'-bipyridine and amino acids. Jain N, Mital R, Ray KS, Srivastava TS, Bhattacharya RK. J Inorg Biochem; 1987 Sep 15; 31(1):57-64. PubMed ID: 3320273 [Abstract] [Full Text] [Related]
12. The key role of coligands in novel ruthenium(II)-cyclopentadienyl bipyridine derivatives: Ranging from non-cytotoxic to highly cytotoxic compounds. Côrte-Real L, Robalo MP, Marques F, Nogueira G, Avecilla F, Silva TJ, Santos FC, Tomaz AI, Garcia MH, Valente A. J Inorg Biochem; 2015 Sep 15; 150():148-59. PubMed ID: 26150132 [Abstract] [Full Text] [Related]
13. [Dipyridyls. VI. Oxidation of 2,5-dihydroxypyridine derivatives]. Nantka-Namirski P, Rykowski A. Acta Pol Pharm; 1976 Sep 15; 33(1):13-7. PubMed ID: 4954 [No Abstract] [Full Text] [Related]
14. Synthesis and evaluation of novel phosphate ester analogs as neutral sphingomyelinase inhibitors. Imagawa H, Oda M, Takemoto T, Yamauchi R, Yoshikawa T, Yamamoto H, Nishizawa M, Takahashi H, Hashimoto M, Yabiku K, Nagahama M, Sakurai J. Bioorg Med Chem Lett; 2010 Jul 01; 20(13):3868-71. PubMed ID: 20627555 [Abstract] [Full Text] [Related]
15. Synthesis, structures and antitumor activity of the first crown ester-linked bipyridyl platinum complexes. Yoo J, Sohn YS, Do Y. J Inorg Biochem; 1999 Mar 01; 73(3):187-93. PubMed ID: 10331247 [Abstract] [Full Text] [Related]
16. Methyl-cyclopentadienyl Ruthenium Compounds with 2,2'-Bipyridine Derivatives Display Strong Anticancer Activity and Multidrug Resistance Potential. Côrte-Real L, Teixeira RG, Gírio P, Comsa E, Moreno A, Nasr R, Baubichon-Cortay H, Avecilla F, Marques F, Robalo MP, Mendes P, Ramalho JPP, Garcia MH, Falson P, Valente A. Inorg Chem; 2018 Apr 16; 57(8):4629-4639. PubMed ID: 29611696 [Abstract] [Full Text] [Related]
17. First synthesis of caerulomycin B. A new synthesis of caerulomycin C. Mongin F, Trécourt F, Gervais B, Mongin O, Quéguiner G. J Org Chem; 2002 May 17; 67(10):3272-6. PubMed ID: 12003535 [Abstract] [Full Text] [Related]
18. Dinuclear RuII(bipy)2 Derivatives: Structural, Biological, and in Vivo Zebrafish Toxicity Evaluation. Lenis-Rojas OA, Roma-Rodrigues C, Fernandes AR, Marques F, Pérez-Fernández D, Guerra-Varela J, Sánchez L, Vázquez-García D, López-Torres M, Fernández A, Fernández JJ. Inorg Chem; 2017 Jun 19; 56(12):7127-7144. PubMed ID: 28585811 [Abstract] [Full Text] [Related]
19. [Synthesis of potential antitumor agents: nitrogen mustards based on quinoline]. Pellerano C, Savini L. Farmaco Sci; 1984 Aug 19; 39(8):681-5. PubMed ID: 6479326 [Abstract] [Full Text] [Related]
20. The 2,2'-bipyridyl-6-carbothioamide copper (II) complex differs from the iron (II) complex in its biochemical effects in tumor cells, suggesting possible differences in the mechanism leading to cytotoxicity. Nocentini G, Barzi A. Biochem Pharmacol; 1996 Jul 12; 52(1):65-71. PubMed ID: 8678909 [Abstract] [Full Text] [Related] Page: [Next] [New Search]